French purification specialist Novasep has said it plans to invest €30 million in a new plant at its site in …
Boehringer Ingelheim has decided to close down one of its active pharmaceutical ingredient (API) manufacturing facilities in the US because …
The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …
Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …

Swiss contract manufacturing organisation Siegfried has announced plans to build a new manufacturing facility in Nantong, near Shanghai in China. …

Merck & Co has decided to close down part of a US plant operated by subsidiary Cherokee Pharmaceuticals after failing …
Fine chemicals, polymers and catalysts specialist Albemarle has brought new manufacturing capacity for active pharmaceutical ingredients (APIs) online at its …

Akzo Nobel has brought a manufacturing facility for active pharmaceutical ingredients in Mexico that failed an inspection last year back …
Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …
The World Health Organization will join a shared inspection programme for active pharmaceutical ingredient (API) facilities piloted last year by …
A two-year facility inspection programme carried out by regulators in the USA, Europe and Australia has been deemed a success …
Drugmakers are increasingly using more sophisticated excipients and blends in order to defend against generic competition, according to new market …
GlaxoSmithKline has started pilot testing of a wireless system of flow and pressure transmitters to try to improve the efficiency …
Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …
Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …